™️ 2022
Learning Lounge
Study: Pneumonia in the ImmunoCompromised - Use of the Karius Test® for the Detection of Undiagnosed Pathogens
Pneumonia is a common infectious cause of morbidity and mortality in patients with hematologic malignancies and those post hematopoietic cell transplantation (HCT). The PICKUP study, a multi-center, prospective study, interrogates this population for the etiology of pneumonia by comparing the performance of the Karius Test to the adjudicated Standard of Care (SOC). During this presentation, results will be shared on the additive diagnostic value of the Karius Test when used in conjunction with SOC for the diagnosis of suspected pneumonia.
Assistant Professor of Medicine - Duke University School of Medicine
Evening Reception
PICKUP the Conversation with Karius at IDWeek 2022
Come meet the Karius team, learn more about our latest multi-center PICKUP Study, and converse with fellow clinicians using the Karius Test in their clinical practice.
What is the Karius Test?
.svg)
.svg)
*The Karius Test® was developed and its performance characteristics determined by Karius. This test has not been cleared or approved by the FDA, nor is it required to be. The Karius laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited by the College of American Pathologists (CAP) to perform high-complexity clinical laboratory testing.